Form 4: Masimo CFO Reports Final Equity Exit Following Merger

Micah W. Young, EVP and CFO of Masimo Corporation, reports the final disposition of all equity holdings following the company's acquisition by Danaher Corporation.

Summary

• Micah W. Young, EVP and CFO, disposed of his entire beneficial ownership in Masimo Corporation common stock and derivative securities on June 10, 2026.
• The disposition occurred as a result of the completed merger between Masimo Corporation and Danaher Corporation.
• Common stock shares were converted into the right to receive $180.00 per share in cash.
• Outstanding stock options were canceled and converted into cash payments based on the spread between the $180.00 merger consideration and the respective exercise prices.
• Performance-based restricted stock units (PSUs) were settled at target performance levels for $180.00 per share.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing documenting the final equity settlement of an executive following a completed corporate acquisition.

Positives

• The merger provided shareholders and executives with a definitive cash exit at $180.00 per share.
• All outstanding equity awards, including unvested options and PSUs, were successfully converted into cash or assumed by the parent company.

Negatives

• The reporting person no longer holds any equity interest in the issuer as it has become a wholly owned subsidiary of Danaher Corporation.

Risks

• The issuer is no longer a publicly traded entity, eliminating future investment opportunities in the standalone company.

Future Outlook

The company has been acquired by Danaher Corporation and now operates as a wholly owned subsidiary; no further independent guidance or outlook is provided.

Industry Context

StockSavvy.ai notes that this filing marks the formal conclusion of Masimo's tenure as an independent public company, reflecting the ongoing consolidation trend within the medical technology sector where larger conglomerates like Danaher are acquiring specialized high-growth assets.

Comparison to Industry Standards

• The $180.00 per share cash consideration represents a standard exit strategy for public company acquisitions in the med-tech space.
• The treatment of unvested equity and options aligns with standard change-in-control provisions found in executive compensation agreements.

Stakeholder Impact

• Shareholders have received the cash merger consideration.
• The reporting person has exited their equity position in the company.

Next Steps

• None; the company is now a subsidiary of Danaher Corporation.

Key Dates

Keywords

Masimo, Danaher, Merger, Acquisition, Form 4, Insider Transaction, CFO